Quantinno Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Quantinno Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39,781	Closed	-$575K	–	3472
2026 Q1	$575K	Buy	39,781 +4,801	+14%	+$68.8K	﹤0.01%	2610
2025 Q4	$498K	Buy	34,980 +5,858	+20%	+$57.5K	﹤0.01%	2436
2025 Q3	$229K	Buy	+29,122	New	+$207K	﹤0.01%	2665
2025 Q2	–	Sell	-11,717	Closed	-$95.6K	–	2597
2025 Q1	$95.6K	Buy	+11,717	New	+$108K	﹤0.01%	2038

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Quantinno Capital Management's FOLD Position: Q2 2026 in Review

Quantinno Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 39,781 shares — an estimated $575K sold.

Quantinno Capital Management first reported a position in FOLD in Q1 2025 and held it in 4 quarters. The position peaked at $575K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Quantinno Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Quantinno Capital Management sold 39,781 Amicus Therapeutics shares in Q2 2026, an estimated $575K.
Quantinno Capital Management first reported a position in Amicus Therapeutics in Q1 2025 and held it in 4 quarters.
Quantinno Capital Management's Amicus Therapeutics position peaked at $575K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.